• Users Online: 965
  • Print this page
  • Email this page
This article has been cited by
1Therapeutic efficacy and safety of oral tranexamic acid 250 mg once a day versus 500 mg twice a day: a comparative study
Bhumika Chowdhary,Vikram K. Mahajan,Karaninder S. Mehta,Pushpinder S. Chauhan,Vikas Sharma,Anuj Sharma,Sanket Vashist,Prabal Kumar
Archives of Dermatological Research.2021;313(2)109
[DOI]
2Therapeutic efficacy and safety of oral tranexamic acid 250 mg once a day versus 500 mg twice a day: a comparative study
Marco Dal Canton
Archives of Dermatological Research.2020;313(2)369
[DOI]
3New oral and topical approaches for the treatment of melasma
P.E. Grimes,S. Ijaz,R. Nashawati,D. Kwak
International Journal of Women's Dermatology.2019;5(1)30
[DOI]
4Randomized control trial outcomes of tranexamic acid combination serum as a depigmenting agent for the use in healthy individuals
Anis I. Anwar,Siswanto Wahab,Widya Widita,Airin R. Nurdin,Suci Budhiani,Arifin Seweng
Dermatologic Therapy.2019;32(6)30
[DOI]
5A split face randomized controlled trial comparing 1,064 nm Q-switched Nd-YAG laser and modified Kligman’s formulation in patients with melasma in darker skin
Tanvi Dev,Vishnubhatla Sreenivas,Vinod K. Sharma,Kanika Sahni,Neetu Bhari,Gomathy Sethuraman
International Journal of Dermatology.2020;59(12)1525
[DOI]
6The color of skin: brown diseases of the skin, nails, and mucosa
Zekayi Kutlubay,Seher Küçükoglu Cesur,Özge Askin,Yalçin Tüzün
Clinics in Dermatology.2019;37(5)487
[DOI]
7Melasma and thyroid disorders: a systematic review and meta-analysis
Motahhareh Kheradmand,Mahdi Afshari,Giovanni Damiani,Saeid Abediankenari,Mahmood Moosazadeh
International Journal of Dermatology.2019;58(11)1231
[DOI]
  Feedback 
  Subscribe 
  Search 
  Advanced Search 
  Apply as Reviewer